141 related articles for article (PubMed ID: 26350702)
21. Theory of mind in schizophrenia: the role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions.
Abdel-Hamid M; Lehmkämper C; Sonntag C; Juckel G; Daum I; Brüne M
Psychiatry Res; 2009 Jan; 165(1-2):19-26. PubMed ID: 19073346
[TBL] [Abstract][Full Text] [Related]
22. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
Cuesta MJ; Peralta V
Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
[TBL] [Abstract][Full Text] [Related]
23. Impairment in test performance and symptom dimensions of schizophrenia.
Eckman PS; Shean GD
J Psychiatr Res; 2000; 34(2):147-53. PubMed ID: 10758257
[TBL] [Abstract][Full Text] [Related]
24. Are negative symptoms really related to cognition in schizophrenia?
Bagney A; Dompablo M; Santabárbara J; Moreno-Ortega M; Lobo A; Jimenez-Arriero MA; Palomo T; Rodriguez-Jimenez R
Psychiatry Res; 2015 Dec; 230(2):377-82. PubMed ID: 26454405
[TBL] [Abstract][Full Text] [Related]
25. [Subjective cognition in schizophrenia].
Potvin S; Aubin G; Stip E
Encephale; 2017 Feb; 43(1):15-20. PubMed ID: 26923995
[TBL] [Abstract][Full Text] [Related]
26. The relationship of Theory of Mind with symptoms and cognitive impairment in bipolar disorder: a prospective study.
Ioannidi N; Konstantakopoulos G; Sakkas D; Oulis P
Psychiatriki; 2015; 26(1):17-27. PubMed ID: 25880380
[TBL] [Abstract][Full Text] [Related]
27. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
[TBL] [Abstract][Full Text] [Related]
28. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
[TBL] [Abstract][Full Text] [Related]
29. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
[TBL] [Abstract][Full Text] [Related]
30. Factor analytic support for social cognition as a separable cognitive domain in schizophrenia.
Allen DN; Strauss GP; Donohue B; van Kammen DP
Schizophr Res; 2007 Jul; 93(1-3):325-33. PubMed ID: 17498927
[TBL] [Abstract][Full Text] [Related]
31. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
[TBL] [Abstract][Full Text] [Related]
32. Psychopathology, cognitive function, and social functioning of patients with schizophrenia.
Santosh S; Dutta Roy D; Kundu PS
East Asian Arch Psychiatry; 2013 Jun; 23(2):65-70. PubMed ID: 23807631
[TBL] [Abstract][Full Text] [Related]
33. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
34. [Neurocognitive subtypes of schizophrenia according to performance at verbal fluency tasks].
Robert PH; Thauby S; Migneco V; Chaix I; Caci H; Benoit M; Pringuey D; Darcourt G
Encephale; 1996; 22(6):435-42. PubMed ID: 10901836
[TBL] [Abstract][Full Text] [Related]
35. [Psychopathologic and cognitive investigations in schizophrenia].
Farkas M
Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
[TBL] [Abstract][Full Text] [Related]
36. Investigation of clinical factors influencing cognitive function in Japanese schizophrenia.
Kishi T; Moriwaki M; Kawashima K; Okochi T; Fukuo Y; Kitajima T; Furukawa O; Naitoh H; Fujita K; Iwata N
Neurosci Res; 2010 Apr; 66(4):340-4. PubMed ID: 20025912
[TBL] [Abstract][Full Text] [Related]
37. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
38. Cognitive inhibition and schizophrenic symptom subgroups.
Williams LM
Schizophr Bull; 1996; 22(1):139-51. PubMed ID: 8685656
[TBL] [Abstract][Full Text] [Related]
39. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
[TBL] [Abstract][Full Text] [Related]
40. Social cognition and quality of life in schizophrenia.
Maat A; Fett AK; Derks E;
Schizophr Res; 2012 May; 137(1-3):212-8. PubMed ID: 22406280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
